Universitätsklinikum Hamburg-Eppendorf: COVID-19 trials
The registry lists 11 COVID-19 studies with Universitätsklinikum Hamburg-Eppendorf as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 2Phase 3 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- COVID-19 Trial of the Candidate Vaccine MVA-SARS-2-S in AdultsWithdrawnNCT05950776Phase 2
- Multicentre Study to Record the Mental and Physical Effects of the COVID-19 Pandemic (COBESITY-Study)Status unknownNCT05303012
- Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 TrialTerminatedNCT05156671Phase 2
- Sex Hormone Dysregulations Are Associated With Critical Illness in COVID-19 PatientsCompletedNCT04979091
- Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19CompletedNCT04895449Phase 1
- The Impact of the COVID-19 Pandemic on Diabetes ManagementCompletedNCT04821921
- Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Disease (COVID-19) in the Oncology Outpatient SettingStatus unknownNCT04779346
- Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19CompletedNCT04569383Phase 1
- Hamburg Edoxaban for Anticoagulation in COVID-19 StudyCompletedNCT04542408Phase 3
- COVID-19 Child Health Investigation of Latent Disease in HamburgStatus unknownNCT04534608
- Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19CompletedNCT04344080Not applicable